Simvastatin Evokes An Unpredicted Antagonism For Tamoxifen In MCF-7 Breast Cancer Cells
. . Ibrahim AB, Zaki HF, Wadie W, Omran MM, Shouman SA. . Cancer Manag Res. 2019 Nov 28;11:10011-10028. doi: 10.2147/CMAR.S218668. 2019. Abstract PURPOSE: Tamoxifen (TAM) is a non-steroidal antiestrogen drug, used in the prevention and treatment of all stages of hormone-responsive breast cancer. Simvastatin (SIM) is a lipid-lowering agent and has been shown to …
Simvastatin Evokes An Unpredicted Antagonism For Tamoxifen In MCF-7 Breast Cancer Cells Read More »